Pharmaceutical

Moderna’s mRNA influenza vaccine receives $176m boost

Moderna has received a grant of $176m through the RRPV Consortium to expedite the development of mRNA-based pandemic influenza vaccines.

Jul 4, 2024 - 04:00
Moderna’s mRNA influenza vaccine receives $176m boost
Moderna has received a grant of $176m through the RRPV Consortium to expedite the development of mRNA-based pandemic influenza vaccines.
Read the original article

Tags:

Previous Article

Johnson & Johnson gains FDA and EC approvals for TB treatment

Next Article

Left in limbo: When pharma halts rare disease research

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

A rare disease has run through five generations of his family, so he’s built community for others

A rare disease has run through five generations of his ...

Jul 10, 2023

STAT+: Lawmakers press CMS to release new breakthrough device coverage rule

STAT+: Lawmakers press CMS to release new breakthrough ...

May 11, 2023

Podcast #5: Doing Digital Deals in Life Sciences | Deal Structure, Terms, and Series Conclusions

Podcast #5: Doing Digital Deals in Life Sciences | Deal...

Jul 24, 2024